Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

REGN-88 well tolerated and reduces inflammation in phase I trials

June 30, 2010

GSK-1362885 is safe in healthy volunteers and patients with type 2 diabetes

June 30, 2010

Pilot trial finds XOMA-052 beneficial in uveitis of Behcet's disease

June 29, 2010

Interim phase II data reported on ENB-0040 in childhood hypophosphatasia

June 29, 2010

Pooled phase III data show efficacy of tesamorelin in HIV-related lipodystrophy

June 29, 2010

SB-1518 dose selected for phase II evaluation in myelofibrosis

June 29, 2010

Phase III data released on tanezumab in knee osteoarthritis pain

June 29, 2010

Pardoprunox is effective in PD but dose adjustment is needed

June 28, 2010

Phase III data detailed for add-on safinamide in PD

June 28, 2010

First-in-human data presented on MLN-9708 in nonhematologic cancer

June 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...